According to KOBAYASHI Pharmaceutical's latest financial reports and stock price the company's current Operating Margin is 8.13%. At the end of 2022 the company had an Operating Margin of 16.82%.
Year | Operating Margin | Change |
---|---|---|
2022 | 16.82% | -5.56% |
2021 | 17.81% | 0.58% |
2020 | 17.71% | 4.54% |
2019 | 16.94% | 11.97% |
2018 | 15.13% | 4.9% |
2017 | 14.42% | 5.33% |
2016 | 13.69% | -12.47% |
2015 | 15.64% | 1.17% |
2014 | 15.46% | -0.44% |
2013 | 15.53% | 2.56% |
2012 | 15.14% | 49.67% |
2011 | 10.12% | -10.79% |
2010 | 11.34% | -13.14% |
2009 | 13.06% | 87.7% |
2008 | 6.96% | 11.21% |
2007 | 6.26% | 9.71% |
2006 | 5.70% | -4.17% |
2005 | 5.95% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.